Zvavahera Chirenje, MD, FRCOG

Global Health Sciences Faculty Affiliate

Phone: 263-470-4890
UCSF Box: 1224
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start End
HPTN 084 Qualitative Substudy Funding FHI 360 Kenya; Malawi; Uganda; Zimbabwe; Botswana; South Africa; Swaziland HIV/AIDS, Pharmacology and Drug Treatment
UZ-UCSF Clinical Trials Unit NIH National Institute of Allergy and Infectious Disease Zimbabwe Infectious Disease, HIV/AIDS, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF Clinical Trials Unit Magee-Womens Research Institute Zimbabwe HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning, Pediatrics, Newborn and Infant Health
HVTN 120 Protocol Funding (PF) Fred Hutchinson Cancer Research Center Zimbabwe HIV/AIDS
HPTN 082 - Protocol Implementation Funding FHI 360 Zimbabwe HIV/AIDS, Drug and Diagnostics Development
HPTN 084 Development Funding FHI 360 Zimbabwe HIV/AIDS
HVTN 703/HPTN 081 Protocol Funding (PF) Fred Hutchinson Cancer Research Center Kenya; Malawi; Mozambique; Tanzania; Zimbabwe; Botswana; South Africa HIV/AIDS, Drug and Diagnostics Development, Women's Health
HVTN 107 Protocol Funding (PF) Fred Hutchinson Cancer Research Center Zimbabwe HIV/AIDS
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3 Johns Hopkins University Zimbabwe HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health
The Bixby Center for Global Reproductive Health - Annual Research Day Conference NIH National Institute of Allergy and Infectious Disease Zimbabwe HIV/AIDS
HPTN 081 Protocol Funding - Development Costs FHI 360 Zimbabwe HIV/AIDS, Risk Reduction and Prevention
IMPAACT Yr 08 P1077 CTU MOU #2 - Parirenyatwa Johns Hopkins University Zimbabwe Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North Johns Hopkins University Zimbabwe HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's Johns Hopkins University Zimbabwe HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding FHI 360 Zimbabwe Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding FHI 360 Zimbabwe HIV/AIDS, Family Planning
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding FHI 360 Zimbabwe HIV/AIDS, Drug and Diagnostics Development
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Johns Hopkins University Zimbabwe HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Johns Hopkins University Zimbabwe HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU Johns Hopkins University Zimbabwe HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
University of Zimbabwe-UCSF Clinical Trials Unit NIH National Institute of Allergy and Infectious Disease Zimbabwe HIV/AIDS, Women's Health, Health Systems Strengthening, Training and Capacity Building
UZ-UCSF Clinical Trials Unit NIH National Institute of Allergy and Infectious Disease Zimbabwe Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health